VIA Matrix is a semi-transparent, collagenous membrane allograft.
INTENDED USES: The intended use of VIA Matrix includes the management of wounds, to protect wounds or burns from the surrounding environment to acute and chronic wounds. Potential clinical applications: Wound care, Venous leg ulcers, Dermatology, Surgical dehiscence, Diabetic foot ulcers, Pressure wounds
CLAIMED BENEFITS: May be applied as a tissue barrier or wound covering to help provide protection to the damaged tissue. Layers are not delaminated; structural integrity of the amnion, intermediate/spongy, and chorion is maintained.~240 µm (0.24mm) thick. Shelf life up to 5 years.
The addition of Skin Substitutes or Cellular or Tissue Based Products (CTPs) to certain wounds may afford a healing advantage over dressings and conservative treatments when these options appear insufficient to affect complete healing, after at least a 30 day period of comprehensive conservative therapy. There are currently a wide variety of bioengineered products available for soft tissue coverage to affect closure. • Human skin allografts are derived from donated human skin (cadavers) • Allogeneic matrices are derived from human tissue (fibroblasts or membrane) • Composite matrices are derived from human keratinocytes, fibroblasts and xenogeneic collagen • Acellular matrices are derived from xenogeneic collagen or tissue
For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care